Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study

Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study

Abstract Background Despite the proven efficacy and safety of apremilast to treat plaque psoriasis (PsO), data regarding its real‐world use and patient‐perceived benefits are limited. Objectives Describe apremilast use, persistence and tolerability, and its patient‐perceived benefits and effectivene...

Full description

Bibliographic Details
Main Authors: Pablo de laCueva, Susana Armesto, Encarnacion Montesinos, Francisco Javier García, Ana Maria Morales, Raquel Rivera‐Díaz, Mercedes Hospital, Jordi Mollet, Mar Llamas‐Velasco, Jose‐Manuel Carrascosa, Mercedes García, Jimena Vázquez, Lluís Puig
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:JEADV Clinical Practice
Subjects:
apremilast
plaque psoriasis
prospective
real‐world study
systemic therapy
Online Access:https://doi.org/10.1002/jvc2.155

Internet

https://doi.org/10.1002/jvc2.155

Similar Items